- Publications
Advancing Diversity in Aesthetic Care: Study Highlights Effectiveness of RHA Fillers in Diverse Patient Populations
In a landmark clinical study conducted by Teoxane Laboratories, the effectiveness of Resilient Hyaluronic Acid (RHA) fillers in treating moderate-to-severe facial wrinkles and folds, particularly nasolabial folds (NLFs), among diverse patient populations was explored. This study is pivotal as it addresses a critical gap in aesthetic research, focusing on individuals with higher Fitzpatrick skin types (FSTs) and non-Caucasian racial backgrounds.
In a landmark clinical study conducted by Teoxane Laboratories, the effectiveness of Resilient Hyaluronic Acid (RHA) fillers in treating moderate-to-severe facial wrinkles and folds, particularly nasolabial folds (NLFs), among diverse patient populations was explored. This study is pivotal as it addresses a critical gap in aesthetic research, focusing on individuals with higher Fitzpatrick skin types (FSTs) and non-Caucasian racial backgrounds.
The study, encompassing two pivotal US clinical trials, involved 434 participants across various racial and ethnic backgrounds, ensuring a robust representation of high FST and non-white patient cohorts. Notably, the research highlighted significant improvements in wrinkle severity among patients with high FSTs and non-white racial backgrounds compared to their counterparts with lower FSTs and white patients.
Results demonstrated that POC (people of color) consistently experienced greater improvement in wrinkle severity scores compared to non-POC, as assessed by blinded evaluators over a 15-month period. This underscores the efficacy of Teosyal RHA®2, Teosyal RHA®3, and Teosyal RHA®4 fillers in addressing dynamic facial wrinkles while maintaining natural facial movement.
Furthermore, patient-reported outcomes, including satisfaction levels and adverse event profiles, were comparable across all racial and skin type categories. The incidence of treatment-related adverse events was notably lower among high FST patients, highlighting the safety profile of RHA fillers in diverse populations.
This comprehensive analysis not only supports the efficacy and safety of Teosyal RHA®fillers but also emphasizes the importance of inclusive research practices in aesthetic medicine. By addressing the unique anatomical and physiological characteristics of diverse skin types and facial structures, Teoxane's study contributes valuable insights for healthcare providers aiming to optimize aesthetic outcomes for all patients.